Imperial ChemEng Cast: Researchers in Focus

Episode 7: Making vaccines more accessible with AlphaVectors Biotech

Department of Chemical Engineering, Imperial College London Season 2 Episode 7

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 29:18

 In this episode, Dr Apanpreet Kaur explains how Imperial spinout AlphaVectors Biotech is developing vaccines that may no longer need continuous refrigeration. 

Many vaccines must be kept cold from the moment they are made until they are given to patients. This “cold chain” can be expensive and difficult to maintain, particularly in places with limited infrastructure. AlphaVectors Biotech is developing nanoparticles that can allow vaccines to remain shelf-stable whether at 4°C or 40°C, making it possible to distribute around the world at a fraction of the cost!

Join us to learn how nanotechnology is helping solve one of the biggest challenges in global vaccine access, and hear about the journey of turning university research into a biotechnology company. This episode is ideal for anyone interested in science, entrepreneurship or how new healthcare technologies move from the laboratory into the real world.